|
PT1586314E
(pt)
|
1996-11-15 |
2011-07-01 |
Ajinomoto Kk |
Composição de comprimidos de nateglinida
|
|
GB9713730D0
(en)
|
1997-06-30 |
1997-09-03 |
Ciba Geigy Ag |
Organic compounds
|
|
CO5200844A1
(es)
|
1999-09-17 |
2002-09-27 |
Novartis Ag |
Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
|
|
US6878749B2
(en)
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
|
ATE385421T1
(de)
|
2000-01-21 |
2008-02-15 |
Novartis Pharma Gmbh |
Zusammensetzungen bestehend aus dipeptidylpeptidase-iv inhibitoren und antidiabetica
|
|
AR033390A1
(es)
|
2000-08-22 |
2003-12-17 |
Novartis Ag |
Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
|
|
KR100819358B1
(ko)
*
|
2000-10-18 |
2008-04-04 |
아지노모토 가부시키가이샤 |
나테글리니드 결정의 제조방법
|
|
ATE373635T1
(de)
*
|
2000-10-18 |
2007-10-15 |
Ajinomoto Kk |
Verfahren zur herstellung von acylphenylalaninen
|
|
PT1334721E
(pt)
*
|
2000-10-24 |
2009-06-01 |
Ajinomoto Kk |
Preparações de fármacos hidrofílicos contendo nateglinida
|
|
ES2307653T3
(es)
*
|
2000-10-24 |
2008-12-01 |
Ajinomoto Co., Inc. |
Preparaciones que contienen nateglinida.
|
|
KR100810930B1
(ko)
*
|
2000-10-24 |
2008-03-10 |
아지노모토 가부시키가이샤 |
나테글리니드 b형 결정의 제조방법
|
|
AR035425A1
(es)
*
|
2001-01-30 |
2004-05-26 |
Teijin Ltd |
Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo
|
|
EP1435912A4
(fr)
*
|
2001-09-12 |
2005-03-30 |
Alembic Ltd |
Nouvelle forme de cristal stable de n-(trans-4-isopropylcyclohexyl carbonyl)-d-phenylalanine et procede de preparation correspondant
|
|
JP2005519949A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ノバルティス アクチエンゲゼルシャフト |
ナテグリニドの塩
|
|
WO2003087039A1
(fr)
*
|
2002-04-15 |
2003-10-23 |
Ajinomoto Co., Inc. |
Nouveau cristal de nateglinide
|
|
US7247746B2
(en)
*
|
2002-04-15 |
2007-07-24 |
Novartis, Ag |
Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine
|
|
US7411089B2
(en)
|
2002-04-15 |
2008-08-12 |
Ajinomoto Co., Inc. |
Nateglinide crystals
|
|
RU2324676C2
(ru)
*
|
2002-04-29 |
2008-05-20 |
Байокон Лимитид |
Кристаллический n-(транс-4-изопропилциклогексилкарбонил)-d-фенилаланин формы с для лечения сахарного диабета типа 2 и способ его получения
|
|
WO2003093222A1
(fr)
*
|
2002-04-29 |
2003-11-13 |
Biocon Limited |
Nouvelle forme de n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
|
|
WO2004005240A1
(fr)
*
|
2002-07-03 |
2004-01-15 |
Teva Pharmaceutical Industries Ltd. |
Procede de preparation de nateglinide et de ses intermediaires
|
|
US6861553B2
(en)
*
|
2002-07-03 |
2005-03-01 |
Teva Pharmaceuticals Industries Ltd. |
Process for preparing nateglinide and intermediates thereof
|
|
US7148376B2
(en)
*
|
2002-07-18 |
2006-12-12 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic forms of nateglinide
|
|
US7534913B2
(en)
*
|
2002-07-18 |
2009-05-19 |
Teva Pharmaceutica Industries Ltd. |
Crystalline form of nateglinide
|
|
US20050075400A1
(en)
*
|
2002-07-18 |
2005-04-07 |
Ronit Yahalomi |
Polymorphic forms of nateglinide
|
|
US7420084B2
(en)
*
|
2002-07-18 |
2008-09-02 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic forms of nateglinide
|
|
US7358390B2
(en)
*
|
2002-07-18 |
2008-04-15 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic forms of nateglinide
|
|
WO2004020396A1
(fr)
*
|
2002-08-28 |
2004-03-11 |
Dr. Reddy's Laboratories Limited |
Forme cristalline de nateglinide et procede de preparation correspondant
|
|
US7449519B2
(en)
*
|
2003-02-18 |
2008-11-11 |
Konishi Co., Ltd. |
Curing resin, method for producing same and curing resin composition
|
|
HU227073B1
(hu)
*
|
2003-07-10 |
2010-06-28 |
Richter Gedeon Nyrt |
Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
|
|
US20060004102A1
(en)
*
|
2004-05-07 |
2006-01-05 |
Shlomit Wizel |
Polymorphic forms of nateglinide
|
|
US7425648B2
(en)
|
2005-01-03 |
2008-09-16 |
A.M.S.A. Anonima Materie Sintetiche E. Affini S.P.A. |
Process for the preparation of nateglinide, preferably in B-form
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
GEP20135791B
(en)
|
2005-09-14 |
2013-03-25 |
Takeda Pharmaceutical |
Use of dipeptidyl peptidase inhibitors
|
|
EP2003113A4
(fr)
*
|
2006-03-31 |
2012-07-18 |
Ajinomoto Kk |
Procede de production d'un compose chlorure d'acide carboxylique
|
|
CN103951583B
(zh)
*
|
2006-12-06 |
2016-01-06 |
科内图斯医药公司 |
一种抑制剂的结晶形式
|
|
ES2459468T3
(es)
|
2009-05-15 |
2014-05-09 |
Novartis Ag |
Arilpiridinas como inhibidores de aldosterona sintasa
|
|
PL2435409T3
(pl)
|
2009-05-28 |
2015-01-30 |
Novartis Ag |
Podstawione pochodne aminopropionowe jako inhibitory neprylizyny
|
|
CA2763565A1
(fr)
|
2009-05-28 |
2010-12-02 |
Novartis Ag |
Derives aminobutyriques substitues en tant qu'inhibiteurs de neprilysine
|
|
WO2011041293A1
(fr)
|
2009-09-30 |
2011-04-07 |
Takeda Pharmaceutical Company Limited |
Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
|
|
EP2993169B1
(fr)
|
2009-11-17 |
2017-12-20 |
Novartis AG |
Dérivés de l'arylpyridine comme inhibiteurs de l'aldosterone synthase
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
EP2507234B1
(fr)
|
2009-11-30 |
2014-03-12 |
Novartis AG |
Dérivés d'imidazole en tant qu'inhibiteurs de l'aldostérone synthase
|
|
SI2531501T1
(sl)
|
2010-02-03 |
2014-04-30 |
Takeda Pharmaceutical Company Limited |
Inhibitorji kinaze-1, ki regulirajo signal apoptoze
|
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
UY35144A
(es)
|
2012-11-20 |
2014-06-30 |
Novartis Ag |
Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
|
|
SG11201506018PA
(en)
|
2013-02-14 |
2015-08-28 |
Novartis Ag |
Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
|
|
EP3024845A1
(fr)
|
2013-07-25 |
2016-06-01 |
Novartis AG |
Polypeptides cycliques pour le traitement de l'insuffisance cardiaque
|
|
WO2015013169A2
(fr)
|
2013-07-25 |
2015-01-29 |
Novartis Ag |
Bioconjugués de polypeptides d'apeline synthétiques
|
|
SG11201704758XA
(en)
|
2015-01-23 |
2017-08-30 |
Novartis Ag |
Synthetic apelin fatty acid conjugates with improved half-life
|
|
UY38072A
(es)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
|
|
CN109369443A
(zh)
*
|
2018-11-05 |
2019-02-22 |
扬子江药业集团江苏海慈生物药业有限公司 |
一种新的那格列奈h晶型的制备方法
|